CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-11 | Castillo Kirsten Director | Option exercise · Option (Right to Buy) | −42,000 | 12,000 | ||
| 2022-07-18 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2022-07-18 | Kumar Ramesh Director | Sale | −7,500 | $2.57 | $19K | 0 |
| 2022-07-18 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | +7,500 | 9,000 | ||
| 2022-07-14 | Musunuri Shankar Chief Executive Officer | Option exercise | +150,000 | $0.33 | $50K | 902,540 |
| 2022-07-14 | Musunuri Shankar Chief Executive Officer | Sale | −150,000 | $2.72 | $408K | 752,540 |
| 2022-07-14 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −150,000 | 629,764 | ||
| 2022-06-07 | Zhang Junge Director | Grant or award · Option (Right to Buy) | +140,091 | 140,091 | ||
| 2022-06-07 | Castillo Kirsten Director | Grant or award · Option (Right to Buy) | +140,091 | 140,091 | ||
| 2022-06-07 | WHITTINGTON MARNA C Director | Grant or award · Option (Right to Buy) | +140,091 | 140,091 | ||
| 2022-06-07 | Kompella Uday Director | Grant or award · Option (Right to Buy) | +140,091 | 140,091 | ||
| 2022-06-07 | Kumar Ramesh Director | Grant or award · Option (Right to Buy) | +140,091 | 140,091 | ||
| 2022-06-07 | Fernandes Prabhavathi Director | Grant or award · Option (Right to Buy) | +140,091 | 140,091 | ||
| 2022-05-13 | Musunuri Shankar Chief Executive Officer | Option exercise | +125,000 | $0.33 | $41K | 877,540 |
| 2022-05-13 | Musunuri Shankar Chief Executive Officer | Sale | −125,000 | $1.92 | $240K | 752,540 |
| 2022-05-13 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −125,000 | 779,764 | ||
| 2022-04-18 | Kumar Ramesh Director | Option exercise | +7,500 | $0.51 | $4K | 7,500 |
| 2022-04-18 | Kumar Ramesh Director | Sale | −7,500 | $2.83 | $21K | 0 |
| 2022-04-18 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | +7,500 | 16,500 | ||
| 2022-03-21 | WHITTINGTON MARNA C Director | Grant or award · Option (Right to Buy) | +106,383 | 106,383 |
Page 5 of 27 · 525 trades